Sipra develops strawberry-flavored anti-AIDS drug: it promises to reduce infant mortality

Today (1 December) is World AIDS Day, so let’s learn some of the latest medical developments. Data show that every year as many as 80,000 babies and young children die from AIDS, in the blocking and anti-viral treatment more mature at the moment, one of the reasons for this situation includes drug difficulties. After all, swallowing sugar-free pills or drinking alcohol-based syrup can be extremely painful for young children.

Sipra develops strawberry-flavored anti-AIDS drug: it promises to reduce infant mortality

Media reported that India’s second-largest drug maker Cipla (Sipra) newly developed anti-AIDS drug Quadrimune may ease the difficultsituation of the drug, because it first tasted strawberry flavor. At the same time, Quadrimune also has a capsule type, parents or medical staff can be supplemented with more delicious drinks to help children deliver.

Sipra develops strawberry-flavored anti-AIDS drug: it promises to reduce infant mortality

Sipra develops strawberry-flavored anti-AIDS drug: it promises to reduce infant mortality

Photo from DNDi

Quadrimune does not require refrigeration and contains four recommended anti-retroviral ingredients. In terms of cost, babies pay about 50 cents a day for medication, and children between 18 and 26 pounds are less than $1.

The FDA is currently reviewing Quadrimune, which is expected to go on the market as soon as 2020, and is highly optimistic about its future role in Africa.

Add a Comment

Your email address will not be published. Required fields are marked *